Zydus Lifesciences to launch Semaglutide Injection in India after patent expiry
Company plans rollout under SEMAGLYN, MASHEMA and ALTERME brands with adjustable single-pen device
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
B&R India hosts Innovations Day 2026 to showcase smart manufacturing solutions
Event highlights intelligent automation, industry collaboration, and next-generation motion control technologies
Biocon receives US FDA approval for Liraglutide Injection gSaxenda
Approval covers 18 mg/3 mL prefilled pens for chronic weight management in the United States
Lupin receives US FDA approval for Brivaracetam Oral Solution 10 mg/mL
Company initiates US launch following ANDA approval for bioequivalent to Briviact
Kiran Mazumdar-Shaw awarded Honorary Fellowship of the UK Academy of Medical Sciences
Biocon Group Chairperson recognised for contributions to biomedical science and access to medicines
DGFT rationalises RoDTEP scheme, reduces benefits by 50 per cent
Value caps under the scheme have also been reduced by 50 per cent wherever applicable
FDA reversal on Moderna’s mRNA-1010 can transform the seasonal influenza vaccines market: GlobalData
GlobalData highlights that the FDA’s review of Moderna’s mRNA-1010, with a 05 August 2026 PDUFA date, could introduce the first…
NIT Rourkela startup receives CDSCO approval for StopBleed Hemostat
Institute spinout Miraqules MedSolutions secures regulatory clearance for technology aimed at emergency haemorrhage control
Alembic Pharmaceuticals receives USFDA approval for Efinaconazole Topical Solution, 10%
Product is therapeutically equivalent to Jublia; company holds 234 USFDA ANDA approvals
US and Japan present narrower path for Alzheimer’s drug approvals: GlobalData
Only two monoclonal antibodies approved in both markets with no small molecules cleared
Eris Lifesciences partners Natco Pharma to commercialise Semaglutide in India
CDSCO approval enables planned March 2026 launch targeting Type 2 diabetes management
Lupin receives European Commission approval for biosimilar ranibizumab RanluspecTM
Following positive CHMP opinion, Lupin to commercialise RanluspecTM in EU through Sandoz partnership
Dr Reddy’s submits Abatacept Biosimilar BLA to USFDA for review
351(k) Biologics License Application for DRL_AB IV infusion targets rheumatoid arthritis, psoriatic arthritis and pJIA
Morepen Laboratories secures ₹825 Cr CDMO mandate from global pharma company
Multi-year contract to commence supplies within 4–5 months, execution planned through Q1 of next financial year
Global Pain Therapeutics market shows scope for non-opioid Innovation: GlobalData
Report highlights voltage-gated sodium channel inhibitors, pipeline trends and regulatory incentives in pain treatment
Queensland delegation concludes BioAsia 2026 mission to expand India–Australia life sciences ties
TIQ and Austrade engage with Indian biotech, clinical trials and MedTech stakeholders during Hyderabad and Bengaluru visit
Cadila Pharmaceuticals marks 100th birth anniversary of Founder Chairman Indravadan Modi
Company commemorates centenary of founder and recalls his role in building India’s pharma manufacturing base
When companies break bad: Directors’ liability under Drugs and Cosmetics Act, 1940
Vineet Unnikrishnan and Sonu Bhasi, Cyril Amarchand Mangaldas; examine the scope of directors’ liability and vicarious…
Zydus Lifesciences launches Anyra, biosimilar of Aflibercept 2 mg in India
Company signs agreement with Regeneron Pharmaceuticals and Bayer for ophthalmic therapy
Dr Reddy’s Laboratories acquires Progynova and Cyclo-Progynova trademarks from Mercury Pharma for…
Acquisition strengthens gynaecology portfolio and marks entry into hormone replacement therapy segment